Literature DB >> 5337774

Evaluation of fluorescein isothiocyanate-labeled whole antiserum in the immunofluorescent identification of microorganisms.

G H Sweet, C A Schindler.   

Abstract

Portions of a whole antiserum to Histoplasma capsulatum were reacted with amounts of fluorescein isothiocyanate (FITC) that ranged from 50 to 400 mug/mg of protein. Portions of the globulin from the same antiserum were reacted with amounts of FITC that ranged from 12.5 to 50 mug of FITC per mg of protein. The globulin conjugates (postlabeled globulins), the whole serum conjugates, and the globulins from the whole serum conjugates (prelabeled globulins) were compared with respect to their fluorescein-protein (F:P) ratios and fluorescent-antibody (FA) activities. The whole serum sample treated with 50 mug of FITC per mg of protein was least reactive in FA tests, and its globulin had the lowest F:P. All other conjugates had globulins with F:P ratios that were considered to be adequate for high FA activity. It was found, however, that the prelabeled globulins were considerably less reactive than the postlabeled globulins or the whole serum conjugates. A larger amount of brightly staining reagent per milliliter of original serum could be obtained from labeled whole serum than from postlabeled globulin. Lissamine-rhodamine conjugated to bovine serum albumin (LRBSA) was evaluated as a counterstain to be used in conjunction with FITC-labeled whole antisera. The counterstain was effective in masking nonspecific FITC fluorescence in Formalin-fixed tissues and in culture smears of fungi. Masking was incomplete in culture smears of a bacterium and in blood smears containing a protozoan.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 5337774      PMCID: PMC276714          DOI: 10.1128/jb.93.6.1943-1948.1967

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  11 in total

1.  TECHNICAL CONSIDERATIONS IN THE PREPARATION OF FLUORESCENT-ANTIBODY CONJUGATES.

Authors:  V J LEWIS; W L JONES; J B BROOKS; W B CHERRY
Journal:  Appl Microbiol       Date:  1964-07

2.  FACTORS AFFECTING THE RATE OF REACTION OF FLUORESCEIN ISOTHIOCYANATE WITH SERUM PROTEINS.

Authors:  R M MCKINNEY; J T SPILLANE; G W PEARCE
Journal:  J Immunol       Date:  1964-08       Impact factor: 5.422

3.  Labeling procedures employing crystalline fluorescein isothiocyanate.

Authors:  C W GRIFFIN; T R CARSKI; G S WARNER
Journal:  J Bacteriol       Date:  1961-10       Impact factor: 3.490

4.  Superiority of fluorescein isothiocyanate (Riggs) for fluorescent-antibody technic with a modification of its application.

Authors:  J D MARSHALL; W C EVELAND; C W SMITH
Journal:  Proc Soc Exp Biol Med       Date:  1958 Aug-Sep

5.  Immunologic studies of heart tissue. I. Production in rabbits of antibodies reactive with an autologous myocardial antigen following immunization with heterologous heart tissue.

Authors:  M H KAPLAN
Journal:  J Immunol       Date:  1958-04       Impact factor: 5.422

6.  Determination of small quantities of nitrogen in serological precipitates and other biological materials.

Authors:  F LANNI; M L DILLON; J W BEARD
Journal:  Proc Soc Exp Biol Med       Date:  1950-05

7.  Chemical characterization of fluorescein isothiocyanate-protein conjugates.

Authors:  A Jobbágy; K Király
Journal:  Biochim Biophys Acta       Date:  1966-07-27

8.  Fluorescent antibody staining. 3. Preparation of fluorescein-isothiocyanate-labeled antibodies.

Authors:  B T Wood; S H Thompson; G Goldstein
Journal:  J Immunol       Date:  1965-08       Impact factor: 5.422

9.  PREPARATION OF FLUORESCEIN ISOTHIOCYANATE-LABELED GAMMA-GLOBULIN BY DIALYSIS, GEL FILTRATION, AND IONEXCHANGE CHROMATOGRAPHY IN COMBINATION.

Authors:  R E DEDMON; A W HOLMES; F DEINHARDT
Journal:  J Bacteriol       Date:  1965-03       Impact factor: 3.490

10.  Localization of antigen in tissue cells; improvements in a method for the detection of antigen by means of fluorescent antibody.

Authors:  A H COONS; M H KAPLAN
Journal:  J Exp Med       Date:  1950-01-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.